Beta Bionics, Inc. (BBNX)
16.92
+1.22
(+7.80%)
USD |
NASDAQ |
Nov 09, 16:00
16.92
0.00 (0.00%)
After-Hours: 20:00
Beta Bionics Enterprise Value : 619.30M for Nov. 6, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 06, 2026 | 619.30M |
| November 05, 2026 | 607.88M |
| November 04, 2026 | 687.25M |
| November 03, 2026 | 586.68M |
| November 02, 2026 | 630.17M |
| October 30, 2026 | 676.38M |
| October 29, 2026 | 721.50M |
| October 28, 2026 | 736.18M |
| October 27, 2026 | 928.62M |
| October 26, 2026 | 880.78M |
| October 23, 2026 | 807.39M |
| October 22, 2026 | 817.18M |
| October 21, 2026 | 766.08M |
| October 20, 2026 | 730.20M |
| October 19, 2026 | 681.27M |
| October 16, 2026 | 654.63M |
| October 15, 2026 | 706.82M |
| October 14, 2026 | 682.90M |
| October 13, 2026 | 727.48M |
| October 12, 2026 | 736.72M |
| October 09, 2026 | 724.22M |
| October 08, 2026 | 713.34M |
| October 07, 2026 | 748.68M |
| October 06, 2026 | 778.58M |
| October 05, 2026 | 795.98M |
| Date | Value |
|---|---|
| October 02, 2026 | 796.52M |
| October 01, 2026 | 791.63M |
| September 30, 2026 | 797.61M |
| September 29, 2026 | 699.02M |
| September 28, 2026 | 748.95M |
| September 25, 2026 | 793.48M |
| September 24, 2026 | 804.72M |
| September 23, 2026 | 824.06M |
| September 22, 2026 | 851.95M |
| September 21, 2026 | 817.32M |
| September 18, 2026 | 810.57M |
| September 17, 2026 | 789.88M |
| September 16, 2026 | 823.61M |
| September 15, 2026 | 690.92M |
| September 14, 2026 | 578.47M |
| September 11, 2026 | 571.27M |
| September 10, 2026 | 572.17M |
| September 09, 2026 | 609.50M |
| September 08, 2026 | 695.42M |
| September 04, 2026 | 699.47M |
| September 03, 2026 | 721.96M |
| September 02, 2026 | 699.24M |
| September 01, 2026 | 683.72M |
| August 31, 2026 | 723.31M |
| August 28, 2026 | 712.96M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| PROCEPT BioRobotics Corp. | 1.043B |
| Edwards Lifesciences Corp. | 54.95B |
| Intuitive Surgical, Inc. | 153.00B |
| Stryker Corp. | 136.22B |
| Zimmer Biomet Holdings, Inc. | 27.19B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -24.35M |
| Revenue (Quarterly) | 35.50M |
| Total Expenses (Quarterly) | 59.86M |
| EPS Diluted (Quarterly) | -0.5232 |
| Gross Profit Margin (Quarterly) | 57.26% |
| Profit Margin (Quarterly) | -68.59% |
| Earnings Yield | -10.91% |
| Normalized Earnings Yield | -10.91 |